Why it’s so hard for China to promote the use of traditional remedies abroad to treat Covid-19
- There is not enough evidence from randomised controlled trials to establish traditional remedies’ effectiveness in treating the coronavirus, experts say
- Chinese officials and doctors have gone to great lengths to highlight TCM’s impact on bringing the outbreak under control on the mainland

In a little-noticed announcement in April, the Hong Kong government launched a free traditional Chinese medicine (TCM) rehabilitation programme for patients recovering from the coronavirus.
The programme has, however, done little to enhance the role of TCM practitioners in the fight against the pandemic. Not a part of the public hospital system managed by the Hospital Authority, they are not even allowed to diagnose or treat coronavirus patients.

Their disappointment also runs especially deep because about 92 per cent of all coronavirus patients in mainland China have been treated with traditional remedies. “Mainland China gives equal weight to western medicine and TCM. But Hong Kong is not like that,” said Lin Zhixiu, professor and associate director of the School of Chinese Medicine at Chinese University of Hong Kong. “At least, some coronavirus patients in Hong Kong have lost their chance to benefit from it.”

02:09
China allocates US$1.63 billion for urgently needed medical supplies to fight coronavirus